Merck & Co., Inc., Kenilworth, New Jersey, USA.
STATinMED Research, Ann Arbor, Michigan.
J Am Geriatr Soc. 2018 May;66(5):864-870. doi: 10.1111/jgs.15281. Epub 2018 Mar 30.
To study transitions between healthcare settings and quantify the cost burdens associated with different combinations of transitions during a 6-month period before initial Alzheimer's disease (AD) diagnosis so as to investigate how using an episode-of-care approach to payment for specific disease states might apply in AD.
A retrospective observational cohort study.
United States.
A random sample of 8,995 individuals aged 65 to 100 with a diagnosis of AD (International Classification of Diseases, Ninth Revision, Clinical Modification code 331.0) were identified from the Medicare database between January 1, 2011, and June 30, 2014. This analysis identified individuals with AD diagnosed in inpatient (18%), skilled nursing facility (SNF) (1%), hospice (4%), and home and outpatient (77%) settings and analyzed episodes that began in the index setting (defined as the care setting in which the individual was first diagnosed with AD).
Study outcomes included number of transitions between settings, primary discharge diagnoses, and total all-cause healthcare costs during the 6 months after the AD diagnosis.
The average numbers of transitions between care settings were 2.8 originating from an inpatient setting, 2.4 from a SNF, 0.3 from a hospice setting and 0.7 from a home or outpatient setting during 6 months post-AD diagnosis. The overall cost burden during the 6 months after AD diagnosis (including costs incurred at the index setting) was high for individuals diagnosed in a nonambulatory setting (mean $41,468). Individuals diagnosed in an ambulatory setting incurred only $12,597 in costs during the same period.
Episodes of care can be defined and studied in individuals with AD. An episode-of-care approach to payment could encourage providers to use the continuum of care needed for quality medical management in AD more efficiently.
研究医疗保健环境之间的转变,并量化在初始阿尔茨海默病 (AD) 诊断前 6 个月内不同转变组合相关的成本负担,以探讨在 AD 中如何应用按特定疾病状态的医疗护理期支付方式。
回顾性观察队列研究。
美国。
从 2011 年 1 月 1 日至 2014 年 6 月 30 日期间,从医疗保险数据库中随机抽取了 8995 名年龄在 65 至 100 岁之间的 AD 患者(国际疾病分类,第九修订版,临床修正代码 331.0)。本分析确定了在住院 (18%)、熟练护理机构 (SNF) (1%)、临终关怀 (4%)和家庭和门诊 (77%)环境中诊断为 AD 的患者,并分析了从指数环境开始的发作 (定义为个体首次被诊断为 AD 的护理环境)。
研究结果包括在 AD 诊断后 6 个月内环境之间的转变次数、主要出院诊断和全因医疗保健总成本。
AD 诊断后 6 个月内,从住院环境开始的平均转变次数为 2.8 次,从 SNF 开始的平均转变次数为 2.4 次,从临终关怀开始的平均转变次数为 0.3 次,从家庭或门诊开始的平均转变次数为 0.7 次。在 AD 诊断后 6 个月内,在非流动环境中诊断的个体的整体成本负担很高(平均为 41468 美元)。在同一时期,在流动环境中诊断的个体仅发生 12597 美元的费用。
可以为 AD 患者定义和研究医疗护理期。按医疗护理期支付方式可以鼓励提供者更有效地利用 AD 质量医疗管理所需的连续护理。